These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 23333927)

  • 21. Proteomics analysis of bladder cancer exosomes.
    Welton JL; Khanna S; Giles PJ; Brennan P; Brewis IA; Staffurth J; Mason MD; Clayton A
    Mol Cell Proteomics; 2010 Jun; 9(6):1324-38. PubMed ID: 20224111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes: Emerging biomarkers and targets for ovarian cancer.
    Tang MK; Wong AS
    Cancer Lett; 2015 Oct; 367(1):26-33. PubMed ID: 26189430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics analysis of Schwann cell-derived exosomes: a novel therapeutic strategy for central nervous system injury.
    Wei Z; Fan B; Ding H; Liu Y; Tang H; Pan D; Shi J; Zheng P; Shi H; Wu H; Li A; Feng S
    Mol Cell Biochem; 2019 Jul; 457(1-2):51-59. PubMed ID: 30830528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
    Kumar D; Gupta D; Shankar S; Srivastava RK
    Oncotarget; 2015 Feb; 6(5):3280-91. PubMed ID: 25682864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic analysis of exosome-like vesicles derived from breast cancer cells.
    Palazzolo G; Albanese NN; DI Cara G; Gygax D; Vittorelli ML; Pucci-Minafra I
    Anticancer Res; 2012 Mar; 32(3):847-60. PubMed ID: 22399603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic analysis of exosomes secreted during the epithelial-mesenchymal transition and potential biomarkers of mesenchymal high-grade serous ovarian carcinoma.
    Ferreira GA; Thomé CH; Izumi C; Grassi ML; Lanfredi GP; Smolka M; Faça VM; Candido Dos Reis FJ
    J Ovarian Res; 2023 Nov; 16(1):232. PubMed ID: 38031074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-grade ovarian cancer secreting effective exosomes in tumor angiogenesis.
    Yi H; Ye J; Yang XM; Zhang LW; Zhang ZG; Chen YP
    Int J Clin Exp Pathol; 2015; 8(5):5062-70. PubMed ID: 26191200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Isolation, identification and clinical significance of ascites-derived exosomes from patients with ovarian epithelial cancer].
    Peng P; You Y; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):268-72. PubMed ID: 19570464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomes: proteomic insights and diagnostic potential.
    Simpson RJ; Lim JW; Moritz RL; Mathivanan S
    Expert Rev Proteomics; 2009 Jun; 6(3):267-83. PubMed ID: 19489699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells.
    Shen X; Wang C; Zhu H; Wang Y; Wang X; Cheng X; Ge W; Lu W
    J Ovarian Res; 2021 Feb; 14(1):38. PubMed ID: 33627162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Techniques Associated with Exosome Isolation for Biomarker Development: Liquid Biopsies for Ovarian Cancer Detection.
    Sharma S; Salomon C
    Methods Mol Biol; 2020; 2055():181-199. PubMed ID: 31502152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian cancer-derived exosomes promote tumour metastasis
    Alharbi M; Lai A; Guanzon D; Palma C; Zuñiga F; Perrin L; He Y; Hooper JD; Salomon C
    Clin Sci (Lond); 2019 Jul; 133(13):1401-1419. PubMed ID: 31227603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Comprehensive Proteomics Analysis Reveals a Secretory Path- and Status-Dependent Signature of Exosomes Released from Tumor-Associated Macrophages.
    Zhu Y; Chen X; Pan Q; Wang Y; Su S; Jiang C; Li Y; Xu N; Wu L; Lou X; Liu S
    J Proteome Res; 2015 Oct; 14(10):4319-31. PubMed ID: 26312558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biological significance and clinical applications of exosomes in ovarian cancer.
    Dorayappan KDP; Wallbillich JJ; Cohn DE; Selvendiran K
    Gynecol Oncol; 2016 Jul; 142(1):199-205. PubMed ID: 27058839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
    Jeppesen DK; Nawrocki A; Jensen SG; Thorsen K; Whitehead B; Howard KA; Dyrskjøt L; Ørntoft TF; Larsen MR; Ostenfeld MS
    Proteomics; 2014 Mar; 14(6):699-712. PubMed ID: 24376083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrin β4 and vinculin contained in exosomes are potential markers for progression of prostate cancer associated with taxane-resistance.
    Kawakami K; Fujita Y; Kato T; Mizutani K; Kameyama K; Tsumoto H; Miura Y; Deguchi T; Ito M
    Int J Oncol; 2015 Jul; 47(1):384-90. PubMed ID: 25997717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic Profiling of Rhabdomyosarcoma-Derived Exosomes Yield Insights into Their Functional Role in Paracrine Signaling.
    Rammal G; Fahs A; Kobeissy F; Mechref Y; Zhao J; Zhu R; Diab-Assaf M; Saab R; Ghayad SE
    J Proteome Res; 2019 Oct; 18(10):3567-3579. PubMed ID: 31448612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intercellular transfer of messenger RNAs in multiorgan tumorigenesis by tumor cell-derived exosomes.
    Jiang H; Li Z; Li X; Xia J
    Mol Med Rep; 2015 Jun; 11(6):4657-63. PubMed ID: 25673258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
    Tauro BJ; Greening DW; Mathias RA; Ji H; Mathivanan S; Scott AM; Simpson RJ
    Methods; 2012 Feb; 56(2):293-304. PubMed ID: 22285593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts.
    Cho JA; Park H; Lim EH; Kim KH; Choi JS; Lee JH; Shin JW; Lee KW
    Gynecol Oncol; 2011 Nov; 123(2):379-86. PubMed ID: 21903249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.